| Literature DB >> 26706621 |
Abstract
An increasing number of studies show that alterations in intestinal microbiota are linked with metabolic diseases. Here, we propose that intestinal microbiota regulation by polyphenols may be an important mechanism underlying their therapeutic benefits for metabolic diseases. This helps elucidate the intriguing pharmacology of polyphenols and optimize the treatment of metabolic diseases.Entities:
Keywords: intestinal microbiota; metabolic diseases; pharmacology; polyphenols
Mesh:
Substances:
Year: 2015 PMID: 26706621 DOI: 10.1016/j.tips.2015.11.010
Source DB: PubMed Journal: Trends Pharmacol Sci ISSN: 0165-6147 Impact factor: 14.819